505(b)(2) Clinical Development Programs

services

Expertise in helping clients and their programs navigate the 505(b)(2) drug development pathway

Supporting 505(b)(2) programs from conceptualization, navigating Pre-IND conversations and meetings, and seamless execution of multi-country trials.

Product Concept Evaluation

  • Candidate identification
  • Feasibility assessment
  • Assessing regulatory pathway
  • Development and execution of clinical development plan
  • Market access, securing code reimbursement and payment

Regulatory Support

  • Pre IND, IND, NDA, and ANDA preparation
  • Submission and Maintenance

Nonclinical strategy and study design, CRO identification & qualification, Project Management

Clinical Study Planning and execution

Orphan Drug Designation

SCIENTIFIC ADVISORY BOARD
REQUEST FOR PORPOSAL